FDG-PET Scanning in Lymphoma and Lymphoma of the Thyroid
作者： I. Ross McDougall
DOI: 10.1007/978-1-59259-995-0_79
关键词:
摘要: Medicare and most insurance companies have approved reimbursement for F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) imaging patients who lymphoma. The instruments methods are described in Chapter 34. In brief, the fast 6 h intravenously administered 10–15 mCi (370–550 MBq) of FDG. After resting a quiet warm environment, patient is imaged from base skull to midthighs. use combined PET/computed (CT) improves diagnostic accuracy, reduces number false-positive results, also increases throughput (1).
springer.com
sci-hub.st 参考文章(28)
Ichiei Kuji, Lale Kostakoglu, Stanley J. Goldsmith, Morton Coleman, John P. Leonard, Holly Zoe, PET Predicts Prognosis After 1 Cycle of Chemotherapy in Aggressive Lymphoma and Hodgkin’s Disease The Journal of Nuclear Medicine. ,vol. 43, pp. 1018- 1027 ,(2002)
Carl K Hoh, John Glaspy, Peter Rosen, Magnus Dahlbom, Shay J Lee, Lori Kunkel, Randall A Hawkin, Jamshid Maddahi, Michael E Phelps, None, Whole-Body FDG-PET Imaging for Staging of Hodgkin's Disease and Lymphoma The Journal of Nuclear Medicine. ,vol. 38, pp. 343- 348 ,(1997)
Jerome S. Burke, James J. Butler, Lillian M. Fuller, Malignant lymphomas of the thyroid.A clinical pathologic study of 35 patients including ultrastructural observations Cancer. ,vol. 39, pp. 1587- 1602 ,(1977) , 10.1002/1097-0142(197704)39:4<1587::AID-CNCR2820390434>3.0.CO;2-V
K. Spaepen, S. Stroobants, P. Dupont, P. Vandenberghe, J. Thomas, T. de Groot, J. Balzarini, C. De Wolf-Peeters, L. Mortelmans, G. Verhoef, Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma Annals of Oncology. ,vol. 13, pp. 1356- 1363 ,(2002) , 10.1093/ANNONC/MDF256
Inga Buchmann, Michael Reinhardt, Klaus Elsner, Donald Bunjes, Carsten Altehoefer, J�rgen Finke, Ernst Moser, Gerhard Glatting, J�rg Kotzerke, Carl A. Guhlmann, Holger Schirrmeister, Sven N. Reske, 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer. ,vol. 91, pp. 889- 899 ,(2001) , 10.1002/1097-0142(20010301)91:5<889::AID-CNCR1078>3.0.CO;2-5
Zayna Nahas, David Goldenberg, Carol Fakhry, Marjorie Ewertz, Martha Zeiger, Paul W. Ladenson, Richard Wahl, Ralph P. Tufano, The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma Laryngoscope. ,vol. 115, pp. 237- 243 ,(2005) , 10.1097/01.MLG.0000154725.00787.00
Lale Kostakoglu, John P. Leonard, Ichiei Kuji, Morton Coleman, Shankar Vallabhajosula, Stanley J. Goldsmith, Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer. ,vol. 94, pp. 879- 888 ,(2002) , 10.1002/CNCR.10336
F. Najjar, R. Hustinx, G. Jerusalem, G. Fillet, P. Rigo, Positron Emission Tomography (PET) for Staging Low-Grade Non-Hodgkin's Lymphomas (NHL) Cancer Biotherapy and Radiopharmaceuticals. ,vol. 16, pp. 297- 304 ,(2001) , 10.1089/108497801753131372
K. D. M. Stumpe, M. Urbinelli, H. C. Steinert, C. Glanzmann, A. Buck, G. K. von Schulthess, Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 25, pp. 721- 728 ,(1998) , 10.1007/S002590050275
Luis Souhami, W.John Simpson, John S. Carruthers, Malignant lymphoma of the thyroid gland. International Journal of Radiation Oncology Biology Physics. ,vol. 6, pp. 1143- 1147 ,(1980) , 10.1016/0360-3016(80)90166-2